pulseline logo

Opposition’s $26 Million For Clinical Trials

[vc_row][vc_column][vc_column_text]In a follow-on announcement from Labor’s signature Medicare Cancer Plan, is an investment of $26 million for clinical trials over four years. With the aim to ensure as many Australians as possible can access trials that can improve patient lives.

The funding will be broken down into three main segments and will be invested in the work of the Australian Clinical Trials Alliance, they include:

  • $12 million to support two research projects – one cancer related
  • $10 million to provide more support for existing Clinical Trial Coordinating Centres
  • $4 million to help ensure that results from clinical trials are quickly implemented

Clinical trials however don’t just benefit patients and the advancement of medical knowledge there are also estimated to be worth around $1 billion to the Australian economy each year.

The environment in which clinical trials are conducted is complex, often occurring across multiple jurisdictions and with every study needing ethics and governance approvals before it can commence.[/vc_column_text][/vc_column][/vc_row]

Related Stories

News, Patients

You have subscribed